{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:45:24Z","timestamp":1793684724592,"version":"4.5.1"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI155634"],"award-info":[{"award-number":["AI155634"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI063302"],"award-info":[{"award-number":["AI063302"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI075039"],"award-info":[{"award-number":["AI075039"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.coi.2024.102508","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:11:17Z","timestamp":1733357477000},"page":"102508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Tuberculosis as an unconventional interferonopathy"],"prefix":"10.1016","volume":"92","author":[{"given":"Russell E","family":"Vance","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2024.102508_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.chom.2018.08.001","article-title":"Alveolar macrophages provide an early Mycobacterium tuberculosis niche and initiate dissemination","volume":"24","author":"Cohen","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"37","key":"10.1016\/j.coi.2024.102508_bib2","doi-asserted-by":"crossref","first-page":"eaaw6693","DOI":"10.1126\/sciimmunol.aaw6693","article-title":"Alveolar macrophages generate a noncanonical NRF2-driven transcriptional response to Mycobacterium tuberculosis in vivo","volume":"4","author":"Rothchild","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20172020","article-title":"Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny","volume":"215","author":"Huang","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2024.102508_bib4","unstructured":"WHO: Global Tuberculosis Report; 2024. \u3008https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024\u3009."},{"key":"10.1016\/j.coi.2024.102508_bib5","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.cell.2014.11.024","article-title":"Host evasion and exploitation schemes of Mycobacterium tuberculosis","volume":"159","author":"Cambier","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.coi.2024.102508_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.chom.2018.06.004","article-title":"Mechanisms of M. tuberculosis immune evasion as challenges to TB vaccine design","volume":"24","author":"Ernst","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2024.102508_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2017.72","article-title":"Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis","volume":"2","author":"Mishra","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coi.2024.102508_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ni.2474","article-title":"Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1beta","volume":"14","author":"Mishra","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.coi.2024.102508_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/microorganisms7070185","article-title":"Tuberculosis progression does not necessarily equate with a failure of immune control","volume":"7","author":"Russell","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.coi.2024.102508_bib11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1146\/annurev-immunol-093019-010426","article-title":"The innate immune response to Mycobacterium tuberculosis infection","volume":"39","author":"Ravesloot-Chavez","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2024.102508_sbref11","doi-asserted-by":"crossref","first-page":"e1011871","DOI":"10.1371\/journal.ppat.1011871","article-title":"Exposure to Mycobacterium remodels alveolarmacrophages and the early innate response to Mycobacterium tuberculosisinfection","volume":"20","author":"Mai","year":"2024","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.coi.2024.102508_bib13","doi-asserted-by":"crossref","first-page":"e20210615","DOI":"10.1084\/jem.20210615","article-title":"Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung","volume":"218","author":"Pisu","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2024.102508_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.chom.2020.10.003","article-title":"Ultra-low dose aerosol infection of mice with Mycobacterium tuberculosis more closely models human tuberculosis","volume":"29","author":"Plumlee","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.coi.2024.102508_bib15","doi-asserted-by":"crossref","first-page":"e00312-17","DOI":"10.1128\/mBio.00312-17","article-title":"Digitally barcoding Mycobacterium tuberculosis reveals in vivo infection dynamics in the macaque model of tuberculosis","volume":"8","author":"Martin","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.coi.2024.102508_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm.3412","article-title":"Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing","volume":"20","author":"Lin","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2024.102508_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mib.2020.01.011","article-title":"Mycobacterium tuberculosis pathogenicity viewed through the lens of molecular Koch's postulates","volume":"54","author":"Ramakrishnan","year":"2020","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.coi.2024.102508_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/science.abq0132","article-title":"A bacterial phospholipid phosphatase inhibits host pyroptosis by hijacking ubiquitin","volume":"378","author":"Chai","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.coi.2024.102508_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2022.2150449","article-title":"Pathogenicity and virulence of Mycobacterium tuberculosis","volume":"14","author":"Rahlwes","year":"2023","journal-title":"Virulence"},{"key":"10.1016\/j.coi.2024.102508_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009712","article-title":"Mycobacterium tuberculosis inhibits the NLRP3 inflammasome activation via its phosphokinase PknF","volume":"17","author":"Rastogi","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2024.102508_bib21","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1016\/j.cell.2022.10.019","article-title":"An ancestral mycobacterial effector promotes dissemination of infection","volume":"185","author":"Saelens","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.coi.2024.102508_bib22","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.220010","article-title":"The aldehyde hypothesis: metabolic intermediates as antimicrobial effectors","volume":"12","author":"Darwin","year":"2022","journal-title":"Open Biol"},{"key":"10.1016\/j.coi.2024.102508_sbref22","article-title":"Disruption of Aldehyde Dehydrogenase 2 protects against bacterial infection","author":"Berry","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.coi.2024.102508_bib24","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153619","article-title":"Mycobacterium tuberculosis: the honey badger of pathogens","volume":"22","author":"Darwin","year":"2021","journal-title":"EMBO Rep"},{"key":"10.1016\/j.coi.2024.102508_bib25","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/eji.201344219","article-title":"Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics","volume":"44","author":"Dorhoi","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nature16451","article-title":"Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection","volume":"528","author":"Kimmey","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.coi.2024.102508_bib27","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1084\/jem.20180118","article-title":"Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection","volume":"215","author":"Nair","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2024.102508_bib28","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1084\/jem.20110919","article-title":"Regulation of neutrophils by interferon-gamma limits lung inflammation during tuberculosis infection","volume":"208","author":"Nandi","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2024.102508_sbref28","article-title":"ATG5 suppresses type I IFN-dependent neutrophil swarming and NETosis","author":"Kinsella","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.coi.2024.102508_bib30","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1128\/IAI.73.3.1744-1753.2005","article-title":"Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice","volume":"73","author":"Eruslanov","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.coi.2024.102508_bib31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41385-020-0300-z","article-title":"Granulocytes act as a niche for Mycobacterium tuberculosis growth","volume":"14","author":"Lovewell","year":"2021","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.chom.2017.09.003","article-title":"M. tuberculosis-induced necrosis of infected neutrophils promotes bacterial growth following phagocytosis by macrophages","volume":"22","author":"Dallenga","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2024.102508_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tube.2013.09.004","article-title":"Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis","volume":"94","author":"Marzo","year":"2014","journal-title":"Tuberculosis"},{"key":"10.1016\/j.coi.2024.102508_bib34","first-page":"1141","article-title":"Lung necrosis and neutrophils reflect common pathways of susceptibility to Mycobacterium tuberculosis in genetically diverse, immune-competent mice","volume":"8","author":"Niazi","year":"2015","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.coi.2024.102508_sbref34","article-title":"Type I IFN signaling mediates NET release to promote Mycobacterium tuberculosis replication and granuloma caseation","author":"Chowdhury","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.coi.2024.102508_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib37","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/infdis\/jiaa708","article-title":"Harmful effects of granulocytic myeloid-derived suppressor cells on tuberculosis caused by hypervirulent mycobacteria","volume":"223","author":"Barbosa Bomfim","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2024.102508_bib38","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1164\/rccm.201405-0828OC","article-title":"Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis","volume":"190","author":"Knaul","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2024.102508_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02761","article-title":"Mycobacterium tuberculosis drives expansion of low-density neutrophils equipped with regulatory activities","volume":"10","author":"La Manna","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19412-6","article-title":"Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis","volume":"11","author":"Moreira-Teixeira","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2024.102508_bib41","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.4049\/jimmunol.1301365","article-title":"Gr-1dimCD11b+ immature myeloid-derived suppressor cells but not neutrophils are markers of lethal tuberculosis infection in mice","volume":"192","author":"Tsiganov","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","article-title":"The type I interferonopathies: 10 years on","volume":"22","author":"Crow","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102280","article-title":"Type-1 interferon-dependent and -independent mechanisms in cyclic GMP-AMP synthase-stimulator of interferon genes-driven auto-inflammation","volume":"80","author":"Gao","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaci.2021.10.027","article-title":"Pathogenic insights from genetic causes of autoinflammatory inflammasomopathies and interferonopathies","volume":"149","author":"Lin","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib45","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.rdc.2023.06.002","article-title":"Type I interferonopathies: a clinical review","volume":"49","author":"Wang","year":"2023","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.coi.2024.102508_bib46","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.coi.2024.102508_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006687","article-title":"Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease","volume":"13","author":"Scriba","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2024.102508_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04579-w","article-title":"A modular transcriptional signature identifies phenotypic heterogeneity of human tuberculosis infection","volume":"9","author":"Singhania","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2024.102508_bib49","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A blood RNA signature for tuberculosis disease risk: a prospective cohort study","volume":"387","author":"Zak","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2024.102508_bib50","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.1224026","article-title":"Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency","volume":"337","author":"Bogunovic","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.coi.2024.102508_bib51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature13801","article-title":"Human intracellular ISG15 prevents interferon-alpha\/beta over-amplification and auto-inflammation","volume":"517","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.coi.2024.102508_bib52","article-title":"A proline deletion in IFNAR1 impairs IFN-signaling and underlies increased resistance to tuberculosis in humans","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2024.102508_bib53","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1089\/jir.2005.25.694","article-title":"Hypervirulent M. tuberculosis W\/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway","volume":"25","author":"Manca","year":"2005","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.coi.2024.102508_bib54","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/s41564-019-0578-3","article-title":"Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1Ra","volume":"4","author":"Ji","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coi.2024.102508_bib55","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.immuni.2011.12.002","article-title":"Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection","volume":"35","author":"Mayer-Barber","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2024.102508_bib56","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.4049\/jimmunol.178.5.3143","article-title":"The type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis","volume":"178","author":"Stanley","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib57","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.4049\/jimmunol.1200255","article-title":"Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis","volume":"188","author":"Desvignes","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib58","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.chom.2012.03.007","article-title":"Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages","volume":"11","author":"Manzanillo","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2024.102508_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17156-x","article-title":"Interferon-independent STING signaling promotes resistance to HSV-1 in vivo","volume":"11","author":"Yamashiro","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2024.102508_bib60","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1172\/JCI40817","article-title":"Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte\/macrophage population","volume":"120","author":"Antonelli","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2024.102508_bib61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature13489","article-title":"Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk","volume":"511","author":"Mayer-Barber","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coi.2024.102508_bib62","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/infdis\/jit424","article-title":"Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway","volume":"209","author":"Redford","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2024.102508_bib63","doi-asserted-by":"crossref","first-page":"e67290","DOI":"10.7554\/eLife.67290","article-title":"Role of the transcriptional regulator SP140 in resistance to bacterial infections via repression of type I interferons","volume":"10","author":"Ji","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.coi.2024.102508_bib64","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.4049\/jimmunol.1300146","article-title":"TPL-2-ERK1\/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production","volume":"191","author":"McNab","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib65","doi-asserted-by":"crossref","unstructured":"Naik SK, McNehlan ME, Mreyoud Y, Kinsella RL, Smirnov A, Chowdhury CS, McKee SR, Dubey N, Woodson R, Kreamalmeyer D, et al.: Type I IFN Signaling in the Absence of IRGM1 Promotes M. tuberculosis Replication in Immune Cells by Suppressing T Cell Responses; bioRxiv. 2023.","DOI":"10.1101\/2023.10.03.560720"},{"issue":"21","key":"10.1016\/j.coi.2024.102508_bib66","doi-asserted-by":"crossref","first-page":"e171982","DOI":"10.1172\/JCI171982","article-title":"IRGM1 supports host defense against intracellular bacteria through suppression of type I interferon in mice","volume":"133","author":"Rai","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2024.102508_bib67","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.2353\/ajpath.2009.081075","article-title":"Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas during chronic tuberculosis infection and reactivation in genetically resistant hosts","volume":"174","author":"Pichugin","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coi.2024.102508_sbref66","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1016\/j.cell.2023.11.002","article-title":"Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis","volume":"186","author":"Kotov","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.coi.2024.102508_bib69","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.chom.2015.05.005","article-title":"Cyclic GMP-AMP synthase is an innate immune DNA sensor for Mycobacterium tuberculosis","volume":"17","author":"Collins","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2024.102508_bib70","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.chom.2015.05.003","article-title":"Mycobacterium tuberculosis differentially activates cGAS- and inflammasome-dependent intracellular immune responses through ESX-1","volume":"17","author":"Wassermann","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2024.102508_bib71","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.chom.2015.05.004","article-title":"The cytosolic sensor cGAS detects Mycobacterium tuberculosis DNA to induce type I interferons and activate autophagy","volume":"17","author":"Watson","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2024.102508_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350666","article-title":"Neutrophil-plasmacytoid dendritic cell interaction leads to production of type I IFN in response to Mycobacterium tuberculosis","volume":"54","author":"Lee","year":"2024","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib73","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1235214","article-title":"Persistent LCMV infection is controlled by blockade of type I interferon signaling","volume":"340","author":"Teijaro","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coi.2024.102508_bib74","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1126\/science.1235208","article-title":"Blockade of chronic type I interferon signaling to control persistent LCMV infection","volume":"340","author":"Wilson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coi.2024.102508_bib75","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.20180325","article-title":"Type I interferons in tuberculosis: foe and occasionally friend","volume":"215","author":"Moreira-Teixeira","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2024.102508_bib76","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.4049\/jimmunol.1100926","article-title":"Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1beta production in human macrophages","volume":"187","author":"Novikov","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib77","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4049\/jimmunol.179.2.1178","article-title":"IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection","volume":"179","author":"Fremond","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib78","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.4049\/jimmunol.0904189","article-title":"Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo","volume":"184","author":"Mayer-Barber","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2024.102508_sbref77","article-title":"Interleukin-1 receptor antagonist is a conserved driver of tuberculosis susceptibility","author":"Kotov","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.coi.2024.102508_bib80","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.immuni.2023.06.023","article-title":"Targeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsis","volume":"56","author":"Gander-Bui","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2024.102508_bib81","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/j.cell.2022.07.004","article-title":"From rare disorders of immunity to common determinants of infection: following the mechanistic thread","volume":"185","author":"Casanova","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.coi.2024.102508_bib82","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2024.102508_bib83","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2024.102508_bib84","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109195","article-title":"Type I interferon decreases macrophage energy metabolism during mycobacterial infection","volume":"35","author":"Olson","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2024.102508_bib86","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4049\/jimmunol.1600266","article-title":"HIF-1\u03b1 is an essential mediator of IFN-\u03b3-dependent immunity to Mycobacterium tuberculosis","volume":"197","author":"Braverman","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib87","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cyto.2012.12.005","article-title":"Inhibition of the type I immune responses of human monocytes by IFN-alpha and IFN-beta","volume":"61","author":"de Paus","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.coi.2024.102508_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006388","article-title":"Down regulation of macrophage IFNGR1 exacerbates systemic L. monocytogenes infection","volume":"13","author":"Eshleman","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2024.102508_bib89","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1084\/jem.20091746","article-title":"Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma","volume":"207","author":"Rayamajhi","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2024.102508_bib90","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.1233665","article-title":"Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses","volume":"339","author":"Teles","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coi.2024.102508_bib91","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.4049\/jimmunol.1401088","article-title":"IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-gamma for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages","volume":"193","author":"McNab","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib92","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.chom.2021.02.005","article-title":"TGFbeta restricts expansion, survival, and function of T cells within the tuberculous granuloma","volume":"29","author":"Gern","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2024.102508_bib93","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"van der Poll","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2024.102508_sbref92","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102365","article-title":"Granulocytes subsets and their divergent functions in host resistance to Mycobacterium tuberculosis - a 'tipping-point' model of disease exacerbation","volume":"84","author":"Mayer-Barber","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2024.102508_bib95","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-immunol-020711-075030","article-title":"Tolerance of infections","volume":"30","author":"Ayres","year":"2012","journal-title":"Annu Rev Immunol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791524000980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791524000980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T16:06:54Z","timestamp":1749571614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791524000980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":95,"alternative-id":["S0952791524000980"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2024.102508","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberculosis as an unconventional interferonopathy","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2024.102508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102508"}}